BriaCell Therapeutics BCTX Cash Flow Statement (2021-2026)

NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BriaCell Therapeutics Quarterly Cash Flow Statement

Periods 22 quarters
Latest Apr 2026

BriaCell Therapeutics reported cash from operations of -$7.02M and free cash flow of -$7.02M for the quarter ended Apr 2026, up 2.0% year over year. This cash flow statement covers 22 quarters of results from Jan 2021 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income
-2.72M-2.28M-3.87M-4.84M-5.15M-1.11M-11.88M-4.90M-2.42M5.96M-11.33M1.69M-1.25M-5.83M-6.34M-6.22M-8.16M-8.28M-7.30M-7.24M
Depreciation and Depletion
0.02M0.02M0.02M0.02M0.02M0.02M0.03M
Share-based Compensation
-0.04M0.52M0.81M0.86M0.88M1.11M0.27M0.28M0.53M0.53M0.50M0.39M0.38M0.27M0.29M0.22M0.29M0.29M0.43M
Cash from Operations
-1.95M-1.78M-2.56M-4.82M-3.33M-3.54M-3.95M-5.33M-10.92M-7.61M-7.40M-5.08M-4.04M-6.96M-5.92M-7.16M-8.13M-7.70M-7.97M-7.02M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Depreciation & Amortization (CF)Depreciation & Amortization
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.06M0.02M0.02M0.03M0.01M0.02M0.02M0.03M
Change in Working Capital
Change in Receivables
-0.02M0.01M0.01M-0.01M0.01M0.01M-0.02M0.01M0.00M0.00M0.01M-0.01M0.74M-0.74M0.01M-0.01M-514.00
Change in Account Payables
0.31M0.03M0.28M-0.31M0.24M0.33M-0.21M0.41M0.13M-0.69M3.28M2.71M0.75M-2.94M0.77M-1.72M0.00M-1.15M-0.25M0.29M
Change in Accured Expenses
-0.15M-0.11M0.07M0.33M-0.30M-0.09M0.30M0.29M-0.07M-0.40M0.12M-0.04M0.46M-0.18M0.82M-0.36M0.49M0.12M0.11M
Investing Activities
Cash from Investing Activities
-0.46M-0.07M-0.07M-0.10M-7.39M-0.07M7.28M-16.00M
Financing Activities
Debt Issuance and Repayment
Non-Current Debt
0.12M
Change in Capital Stock
Net Equity Issued and Repurchased
1.38M4.00M11.67M4.69M14.71M13.56M
Misc.
Cash from Financing Activities
38.29M1.37M-0.16M-0.05M0.00M4.00M11.96M5.22M14.71M13.56M
Exchange Rate Effect
Change in Cash
36.35M-1.78M-7.51M-3.45M-3.49M-3.59M-3.95M-5.33M-6.92M-7.61M-7.40M-5.31M-0.07M4.93M-0.78M7.45M-1.97M-7.78M27.19M-23.02M
Free Cash Flow
-1.95M-1.78M-2.56M-4.82M-3.33M-3.54M-3.95M-5.33M-10.92M-7.61M-7.40M-5.08M-4.04M-6.96M-5.92M-7.16M-8.13M-7.70M-7.97M-7.02M
Net Cash Flow
36.35M-1.78M-2.56M-3.45M-3.49M-3.59M-3.95M-5.33M-6.92M-7.61M-7.40M-5.08M-4.49M4.93M-0.78M7.45M-1.97M-7.78M-0.68M-23.02M

BriaCell Therapeutics Cash Flow Statement API

Pull BriaCell Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY